For decades, Americans have paid the highest prescription drug prices in the developed world, often subsidizing lower costs overseas. This episode of Perspective examines how President Trump’s healthcare plan places drug pricing reform at the center of fixing a broken system, focusing on the role of generic drugs, the distortions caused by international price controls, and the promise and controversy of Most Favored Nation pricing. With expert analysis by Jon Potter, executive director at The Coalition Against Pharma Patent Abuse, and Dr. Ken Berry, this program explores whether confronting pharmaceutical costs head-on could finally lower prices for American patients and permanently reset the healthcare market.
